研究成果

全部

期刊文章

依作者

主題

1 [sdgs]sdg3
1 axitinib; hepatitis b surface antigen; sorafenib; antineoplastic agent; axitinib; carbanilamide derivative; nicotinamide; sorafenib; adult; anorexia; article; child pugh score; clinical article; constipation; controlled study; drug efficacy; drug safety; dyspnea; fatigue; female; hand foot syndrome; human; hypertension; liver cell carcinoma; male; middle aged; mucosa inflammation; multicenter study; nausea; overall survival; phase 2 clinical trial; priority journal; progression free survival; proteinuria; treatment response; vomiting; clinical trial; liver tumor; treatment outcome; antineoplastic agents; axitinib; carcinoma, hepatocellular; humans; liver neoplasms; niacinamide; phenylurea compounds; sorafenib; treatment outcome

依日期

1 2000 - 2024

依類型

1 journal article

全文

1 no fulltext

第 1 到 1 筆結果，共 1 筆。

	公開日期	標題	作者	來源出版物	scopus	WOS	全文
1	2020	A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy	ZHONG-ZHE LIN ; BANG-BIN CHEN ; Hung, Yi-Ping; HUANG, PO-HSIANG ; Ying-Chun Shen ; YU-YUN SHAO ; CHIH-HUNG HSU ; ANN-LII CHENG ; Lee, Rheun-Chuan; Chao, Yee; CHIUN HSU	Oncologist	12	10